Back to Search
Start Over
European Commission Approves Pfizer's VELSIPITY[R] for Patients with Moderately to Severely Active Ulcerative Colitis
- Source :
- Business Wire. February 19, 2024
- Publication Year :
- 2024
-
Abstract
- * VELSIPITY is the first and only oral advanced ulcerative colitis therapy approved for use in patients 16 years of age or older in the EU NEW YORK -- Pfizer [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.782999309